Patent Reform Face-Off Turns To Face Time For Pharma And Tech Companies
Executive Summary
Pushing to craft a final patent reform bill that's acceptable to everyone, Senator Patrick Leahy. D-Vt., called together representatives from the pharmaceutical, biotech, software and financial services industries, universities, labor organizations and inventors. The groups hunkered down with Leahy's staff on Sept. 24 to tweak the bill's provisions